A comprehensive laboratory study from the University of Cambridge has found that approximately three-quarters of the 39 commonly used sweeteners tested directly altered the growth of at least one species of gut bacteria, and that sweetener effects changed in more than 100 ways when the sweeteners were combined with medications, caffeine, or food additives. The strongest observed effect involved the combination of isosteviol, a sweetener used in foods and beverages, with the antidepressant duloxetine, which sharply reduced two bacterial species important for digestive health and blood sugar regulation.
The study, published in Molecular Systems Biology on June 25, 2026, and covered by ScienceDaily on July 16, is one of the most comprehensive experimental analyses of sweetener-microbiome interactions yet conducted.
Why This Matters
Sweeteners have been widely promoted as biologically inert alternatives to sugar, meaning they provide sweetness without calories and pass through the body without significant biological activity. This study challenges that characterization by demonstrating, in laboratory conditions, that many sweeteners can directly alter the behavior of gut bacteria at concentrations that reflect what reaches the colon during normal consumption.
The research matters for two reasons. First, gut microbiome health has increasingly been linked to metabolic, immune, and mental health outcomes in the research literature. Compounds that alter gut bacterial populations are not necessarily harmless. Second, the medication interaction dimension is largely unexplored territory: most drug safety testing does not specifically examine how sweeteners present in medication formulations or the diet interact with the drug's effect on gut bacteria. That gap, which this study begins to illuminate, is clinically significant for the hundreds of millions of people who take regular medications while also consuming sweetened foods and beverages.
What We Know So Far
The Cambridge research team, led by Kiran Raosaheb Patil and published with co-authors including Sonja Blasche and Vinita Periwal, tested 39 commercially available sweeteners, both artificial and naturally derived, on 25 species of gut bacteria grown in laboratory cultures. The bacteria were selected to cover a broad range of the healthy human gut microbiome, including beneficial, neutral, and potentially harmful species.
Key findings, as described in ScienceDaily, SciTechDaily, and the Technology Networks summary of the published paper:
Approximately 75% of the 39 sweeteners altered the growth of at least one bacterial species in laboratory conditions. Some sweeteners slowed or completely stopped the growth of bacteria considered beneficial for gut health, including bacteria important for metabolic regulation and immune function.
Researchers tested 156 combinations of sweeteners with four commonly co-consumed compounds: advantame (another sweetener increasingly used in processed foods), caffeine, vanillin (a common flavoring), and duloxetine (the antidepressant sold under the brand name Cymbalta). They also tested 12 combinations with medications commonly used in tablet formulations that contain acesulfame potassium, a widely used artificial sweetener: ibuprofen, acetaminophen, and cetirizine (an antihistamine).
The most disruptive finding involved isosteviol combined with duloxetine. In laboratory experiments, that combination sharply reduced two bacterial species associated with digestive health and blood sugar regulation. The combination also produced changes consistent with altered inflammatory and immune signaling and appeared to increase toxicity toward certain host cells.
The total number of "unexpected interactions," where a sweetener's effect changed when paired with another compound, exceeded 100 across the 156 sweetener-xenobiotic combinations tested.
Where This Research Applies
The research has the most immediate relevance for people who simultaneously consume sweetened foods or beverages while taking duloxetine or other antidepressants. Duloxetine (Cymbalta) is one of the most widely prescribed antidepressants in the United States, used for major depressive disorder, generalized anxiety disorder, fibromyalgia, and neuropathic pain. Diet beverages, sugar-free foods, and sweetened meal replacements are commonly consumed by people managing metabolic conditions who may also be on psychiatric medications.
Sweeteners are also widely present in medication formulations themselves: acesulfame potassium, for example, is present in many chewable tablets, liquid medications, and children's formulations. The study's finding that this sweetener interacts with ibuprofen, acetaminophen, and cetirizine in laboratory conditions means people are often receiving sweetener-drug combinations passively, without knowing it.
What Doctors and Experts Say
"My take is that sweeteners are still a reasonable short-term tool, but the blanket 'safe sugar alternative' message is increasingly outdated, particularly for patients on multiple medications where these interactions have barely been studied," commented Ahmad, an expert quoted in Newsweek in coverage of the study.
The researchers themselves were careful to limit their conclusions to what the laboratory data supports. They emphasized that the work was conducted entirely in laboratory models, not in human subjects, and that digestion, diet, genetics, and the existing composition of an individual's gut microbiome may alter or override these effects in real life. They explicitly stated that the results do not prove that sweeteners cause health problems in humans.
The study called for future human clinical studies to determine whether the laboratory interactions translate to meaningful clinical effects in people.
What the Evidence Shows and What It Does Not
MedicalDaily Evidence Check
- Study type: In vitro (laboratory) research; bacteria grown in cell cultures, not a human study
- Published in: Molecular Systems Biology (EMBO/Nature); doi: 10.1038/s44320-026-00225-6; published June 25, 2026
- ScienceDaily feature date: July 16, 2026
- Institution: University of Cambridge; European Research Council and UK Medical Research Council funding
- Sweeteners tested: 39 commercially available artificial and natural sweeteners, including aspartame, sucralose, stevia derivatives, sugar alcohols, and others
- Gut bacteria tested: 25 species covering a range of beneficial, neutral, and potentially harmful organisms at concentrations of 50 µM (reflecting typical colon levels)
- Combinations tested: 156 sweetener-xenobiotic combinations; 12 sweetener-drug combinations
- Key finding: Approximately 75% of sweeteners altered the growth of at least one bacterial species; more than 100 interactions changed when sweeteners were combined with other compounds
- Strongest finding: Isosteviol + duloxetine combination sharply reduced two beneficial bacterial species and showed changes associated with inflammation and immune activity in laboratory models
- What it does not prove: That sweeteners cause measurable gut microbiome changes, illness, or medication interactions in human consumers; human trials have not been conducted
- What readers should know: This is laboratory research. Do not stop using sweeteners or change any medication based on this study. Talk with a pharmacist or physician if you are on antidepressants and regularly consume sweetened foods or medications.
Who Should Pay Attention?
This research is most relevant to:
- People who regularly take duloxetine or other antidepressants and consume sweetened foods or beverages
- People who take multiple medications and regularly consume diet beverages or sweetened processed foods
- Pharmacists and prescribers, who may want to consider whether sweetener-drug interactions warrant patient counseling in specific medication scenarios
- Food manufacturers, who include sweeteners in processed foods, beverages, and medication formulations
- Researchers studying the gut microbiome and dietary supplement-drug interactions
For the general public consuming sweeteners in moderate amounts without regular prescription drug use, this research does not constitute a reason to change dietary habits.
What You Can Do Now
- Do not stop using sweeteners or change any medication based on this study. The research was conducted in a laboratory, not in humans, and does not establish health effects in real-life consumption.
- If you take duloxetine (Cymbalta) or another antidepressant regularly and consume sweetened foods or beverages heavily, mention this to your prescribing physician or pharmacist. They can evaluate whether any dietary modifications are appropriate in your specific situation.
- Check the inactive ingredient list on any regular medication you take. If acesulfame potassium or other sweeteners are listed, ask your pharmacist whether these are known to affect the drug's behavior in the gut.
- For people interested in reducing sweetener exposure generally, whole foods with naturally occurring sugars and fiber provide sweetness with established nutritional context.
- Follow updates in this research area through the American Gut Project and peer-reviewed nutrition and microbiome journals, where human studies of sweetener-microbiome interactions will be the next important research step.
Cost and Access: What Patients Should Know
No dietary change or medical intervention is currently indicated by this research. People with concerns about their gut microbiome health who take prescription medications should discuss those concerns with their prescribing physician, who can evaluate dietary and medication interactions in the context of their complete health picture. Consultations with a registered dietitian may also be valuable for people on multiple medications who want personalized dietary guidance.
What Happens Next
The Cambridge team expects this work to catalyze more targeted human studies examining how specific sweetener-medication combinations affect gut microbiome composition and health outcomes in real patients. Such studies would involve longitudinal dietary assessment, microbiome sequencing, and clinical outcome tracking, a significantly more complex research design than laboratory work but the only way to confirm whether laboratory interactions have real-world clinical significance. MedicalDaily will report on any major human clinical trial findings in this area.
The Bottom Line
A University of Cambridge laboratory study found that approximately 75% of 39 tested commercial sweeteners altered gut bacterial growth, and that combining sweeteners with medications, caffeine, or food additives changed the effects in more than 100 ways. The most disruptive combination found was isosteviol with the antidepressant duloxetine. The research does not prove that sweeteners harm gut health in humans, and no dietary change is recommended based on this study alone. People on regular prescription medications, particularly antidepressants, may want to discuss sweetener consumption with their pharmacist as a precaution while the science evolves.
